BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7903215)

  • 1. Vasodilator effect of tertatolol in isolated perfused rat kidneys: involvement of endothelial 5-HT1A receptors.
    Verbeuren TJ
    Cardiology; 1993; 83 Suppl 1():5-9. PubMed ID: 7903215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5-Hydroxytryptamine-induced vasodilatation in the isolated perfused rat kidney: are endothelial 5-HT1A receptors involved?
    Verbeuren TJ; Mennecier P; Laubie M
    Eur J Pharmacol; 1991 Aug; 201(1):17-27. PubMed ID: 1838983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological features of the vasodilation induced by tertatolol in isolated perfused rat kidneys.
    Verbeuren TJ; Herman AG
    Am J Hypertens; 1989 Nov; 2(11 Pt 2):219S-222S. PubMed ID: 2573367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The beta adrenoceptor blocker tertatolol causes vasodilatation in the isolated perfused vasoconstricted rat kidney.
    Verbeuren TJ; Zonnekeyn LL; Prost JF; Rochat C; Thomas JR; Herman AG
    J Pharmacol Exp Ther; 1988 Aug; 246(2):628-34. PubMed ID: 2900328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. (-)-pindolol and (+/-)-tertatolol affect rat hippocampal 5-HT levels through mechanisms involving not only 5-HT1A, but also 5-HT1B receptors.
    Assie MB; Koek W
    Neuropharmacology; 1996 Feb; 35(2):213-22. PubMed ID: 8734491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. (-)Tertatolol is a potent antagonist at pre- and postsynaptic serotonin 5-HT1A receptors in the rat brain.
    Jolas T; Haj-Dahmane S; Lanfumey L; Fattaccini CM; Kidd EJ; Adrien J; Gozlan H; Guardiola-Lemaitre B; Hamon M
    Naunyn Schmiedebergs Arch Pharmacol; 1993 May; 347(5):453-63. PubMed ID: 7686633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prejunctional beta-adrenoceptors in the isolated perfused rat kidney: a comparative study of the beta-blockers tertatolol and propranolol.
    Verbeuren TJ; Zonnekeyn LL; Prost JF; Herman AG
    Arch Int Pharmacodyn Ther; 1989; 298():183-97. PubMed ID: 2569296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasodilatation elicited by 5-HT1A receptor agonists in constant-pressure-perfused rat kidney is mediated by blockade of alpha 1A-adrenoceptors.
    Eltze M; Boer R; Sanders KH; Kolassa N
    Eur J Pharmacol; 1991 Sep; 202(1):33-44. PubMed ID: 1686254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of tertatolol and of its metabolites and structural analogues in isolated perfused rat kidney vasculature.
    Stephan D; Barthelmebs M; Krieger JP; Decker N; Rochat C; Imbs JL
    J Cardiovasc Pharmacol; 1990 Aug; 16(2):338-46. PubMed ID: 1697392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tertatolol, a new beta-blocker, is a serotonin (5-hydroxytryptamine1A) receptor antagonist in rat brain.
    Prisco S; Cagnotto A; Talone D; De Blasi A; Mennini T; Esposito E
    J Pharmacol Exp Ther; 1993 May; 265(2):739-44. PubMed ID: 8496820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study of prejunctional beta-adrenoceptors in kidneys of normotensive and hypertensive rats using the new beta-adrenoceptor blocking drug tertatolol.
    Verbeuren TJ; Herman AG
    Am J Nephrol; 1986; 6 Suppl 2():30-5. PubMed ID: 2879470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of hypothermia as a model of 5-hydroxytryptamine1A receptor-mediated activity in the rat: a pharmacological characterization of the actions of novel agonists and antagonists.
    Millan MJ; Rivet JM; Canton H; Le Marouille-Girardon S; Gobert A
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1364-76. PubMed ID: 8450471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anxiolytic effects in the plus-maze of 5-HT1A-receptor ligands in dorsal raphé and ventral hippocampus.
    File SE; Gonzalez LE
    Pharmacol Biochem Behav; 1996 May; 54(1):123-8. PubMed ID: 8728549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Vasodilator effect of tertatolol on isolated rat kidney].
    Stephan D; Barthelmebs M; Rochat C; Imbs JL
    Arch Mal Coeur Vaiss; 1989 Jul; 82(7):1211-3. PubMed ID: 2573324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-HT2 receptor blockade exhibits 5-HT vasodilator effects via nitric oxide, prostacyclin and ATP-sensitive potassium channels in rat renal vasculature.
    García-Pedraza JA; García M; Martín ML; Rodríguez-Barbero A; Morán A
    Vascul Pharmacol; 2016 Apr; 79():51-59. PubMed ID: 26586311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of vasodilators, including nitric oxide, on the release of cGMP and cAMP in the isolated perfused rat kidney.
    Heuzé-Joubert I; Mennecier P; Simonet S; Laubie M; Verbeuren TJ
    Eur J Pharmacol; 1992 Sep; 220(2-3):161-71. PubMed ID: 1330617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-hydroxytryptamine (5-HT)1A receptors and the tail-flick response. I. 8-hydroxy-2-(di-n-propylamino) tetralin HBr-induced spontaneous tail-flicks in the rat as an in vivo model of 5-HT1A receptor-mediated activity.
    Millan MJ; Bervoets K; Colpaert FC
    J Pharmacol Exp Ther; 1991 Mar; 256(3):973-82. PubMed ID: 1826033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term renal vasodilator effect of the beta-adrenoceptor blocker tertatolol in conscious spontaneously hypertensive rats.
    Nievelstein HN; Tyssen CM; Smits JF; Struyker-Boudier HA
    J Cardiovasc Pharmacol; 1988 Aug; 12(2):252-4. PubMed ID: 2459558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions of (+)- and (-)-8- and 7-hydroxy-2-(di-n-propylamino)tetralin at human (h)D3, hD2 and h serotonin1A receptors and their modulation of the activity of serotoninergic and dopaminergic neurones in rats.
    Lejeune F; Newman-Tancredi A; Audinot V; Millan MJ
    J Pharmacol Exp Ther; 1997 Mar; 280(3):1241-9. PubMed ID: 9067310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pindolol suppresses serotonergic neuronal activity and does not block the inhibition of serotonergic neurons produced by 8-hydroxy-2-(di-n-propylamino)tetralin in awake cats.
    Fornal CA; Martin FJ; Metzler CW; Jacobs BL
    J Pharmacol Exp Ther; 1999 Oct; 291(1):229-38. PubMed ID: 10490909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.